NEWS
We have chosen the most important industry news.
Quick Filters
Results
ALL News Results
Medicare and Alzheimer's Drugs: Pressure To Relax Coverage Restrictions Rising With Donanemab Data
May 07, 2023
Coverage and Access
US health officials aim to 'transform' Alzheimer's disease research with $300 million data platform
April 05, 2023
Clinical Practice
Leqembi Label Recommends Alzheimer's Patient Registry: A Nod To Medicare Evidence Demands?
January 19, 2023
FDA Approvals
FDA Approves New Antibody to Slow Alzheimer's Disease, Even as Safety Concerns Linger
January 06, 2023
FDA Approvals
Alzheimer's Network for Treatment and Diagnostics Created to Collect Real-World Data
December 06, 2022
Clinical Practice
Alzheimer's Association Announces National Data Registry for Quick, Transparent Data Sharing
November 16, 2022
Clinical Practice
A New Alzheimer's Drug Gave Patients Hope. Millions Can't Get It
November 01, 2022
Coverage and Access
Lecanemab Confirmatory Phase 3 Clarity Ad Study Shows Significant Reduction of Clinical Decline
September 28, 2022
Clinical Trials
Alzheimer's Association Launches ALZ-NET Registry for Study of New Treatments for Alzheimer's Disease in Real-World Setting
August 02, 2022
Clinical Practice
Alzheimer’s Association Launches ALZ-NET: A Long-Term Data Collection and Sharing Network for New Treatments
August 01, 2022
Coverage and Access
National Alzheimer Disease Registry Announced to Collect Clinical Practice Data
November 12, 2021
Clinical Practice
Aduhelm May Not Be Perfect, But It May Be a Start - If Patients Can Access It
November 11, 2021
Coverage and Access
Working Towards a World Without Alzheimer's and All Other Dementia
November 01, 2021
Clinical Practice